Yoshikazu Ganchiku, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 2 | 2022 | 4285 | 0.340 |
Why?
|
Graft Rejection | 5 | 2024 | 4505 | 0.330 |
Why?
|
Heart Transplantation | 1 | 2021 | 3291 | 0.290 |
Why?
|
Mice, Inbred BALB C | 3 | 2024 | 6241 | 0.260 |
Why?
|
Liver Transplantation | 3 | 2022 | 2399 | 0.240 |
Why?
|
Transplantation, Homologous | 4 | 2024 | 4834 | 0.200 |
Why?
|
Living Donors | 3 | 2022 | 651 | 0.190 |
Why?
|
Spheroids, Cellular | 1 | 2021 | 332 | 0.160 |
Why?
|
Skin Transplantation | 1 | 2024 | 1097 | 0.160 |
Why?
|
Cell Transplantation | 1 | 2021 | 475 | 0.160 |
Why?
|
Lymphocytes | 2 | 2024 | 2611 | 0.140 |
Why?
|
Animals, Genetically Modified | 1 | 2022 | 1563 | 0.140 |
Why?
|
Interleukin-2 | 1 | 2024 | 1892 | 0.140 |
Why?
|
Graft Survival | 2 | 2024 | 3890 | 0.130 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22365 | 0.130 |
Why?
|
Transplantation, Heterologous | 1 | 2022 | 2393 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2024 | 1175 | 0.110 |
Why?
|
Hepatocytes | 1 | 2021 | 1247 | 0.110 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18390 | 0.110 |
Why?
|
Tissue Donors | 1 | 2022 | 2377 | 0.100 |
Why?
|
Swine | 1 | 2022 | 5996 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4403 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4613 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2331 | 0.080 |
Why?
|
Animals | 7 | 2024 | 169424 | 0.070 |
Why?
|
Mice | 6 | 2024 | 82051 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4362 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10269 | 0.050 |
Why?
|
Adoptive Transfer | 1 | 2024 | 825 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2022 | 228 | 0.050 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2020 | 89 | 0.040 |
Why?
|
Isoantibodies | 1 | 2022 | 682 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2024 | 14483 | 0.040 |
Why?
|
HLA Antigens | 1 | 2022 | 1333 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1840 | 0.030 |
Why?
|
Brain | 1 | 2022 | 27439 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2633 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2834 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3105 | 0.020 |
Why?
|
Humans | 5 | 2024 | 768369 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9425 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13497 | 0.010 |
Why?
|
Male | 3 | 2022 | 364761 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36496 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42620 | 0.010 |
Why?
|
Middle Aged | 2 | 2022 | 223406 | 0.010 |
Why?
|
Adult | 2 | 2022 | 223528 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 65408 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 60038 | 0.010 |
Why?
|
Child | 1 | 2020 | 80856 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89163 | 0.010 |
Why?
|
Aged | 1 | 2020 | 171514 | 0.000 |
Why?
|
Female | 1 | 2020 | 396926 | 0.000 |
Why?
|